Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of leflunomide to control and reverse chronic allograft rejection

Use of leflunomide to control and reverse chronic allograft rejection

US Patent 5624946 · Granted Apr 29, 1997

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Two phase immersion cooling system with useable warmed liquid output2025
Scalable and programmable coherent waveform generators2025
Scalable and programmable coherent waveform generators2024
Scalable and programmable coherent waveform generators2022
Energy absorption for D-ring attachment bracket2021
Method and apparatus for measuring the voltage of a power source2009
Boron ion delivery system2007
Fluorescent lamp power supply and control circuit for wide range operation2000
Fluorescent-lamp excitation circuit with frequency and amplitude control and met2000
Methods and apparatus for obtaining floating output drive to fluorescent lamps a1998
Key ring opener and method of use1998
Use of leflunomide to prevent or control xenograft rejection1997